Daming Gao Selected Research

Daming Gao Research Topics

Disease

27	Neoplasms (Cancer) 11/2023 - 04/2009
10	Carcinogenesis 11/2023 - 07/2012
3	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 01/2021
3	Liver Neoplasms (Liver Cancer) 01/2023 - 01/2017
2	Inflammation (Inflammations) 10/2023 - 01/2022
2	Neoplasm Metastasis (Metastasis) 10/2022 - 01/2019
2	Infections 01/2022 - 11/2021
2	Carcinoma (Carcinomatosis) 05/2020 - 10/2017
2	Genomic Instability 01/2018 - 02/2015
2	Breast Neoplasms (Breast Cancer) 01/2012 - 03/2011
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2023
1	Colorectal Neoplasms (Colorectal Cancer) 11/2023
1	Cholangiocarcinoma 10/2023
1	Insulin Resistance 11/2022
1	Body Weight (Weight, Body) 11/2022
1	Obesity 11/2022
1	Thrombosis (Thrombus) 10/2019
1	Fibrosis (Cirrhosis) 04/2019
1	Epilepsy (Aura) 01/2019
1	Stomach Neoplasms (Stomach Cancer) 01/2019
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2019
1	ACTH-Secreting Pituitary Adenoma 01/2018
1	Autism Spectrum Disorder 01/2018
1	Pituitary ACTH Hypersecretion 01/2018
1	Cushing Syndrome 01/2018
1	Polyploidy 01/2017
1	Chromosomal Instability (Chromosome Stability) 01/2017

Drug/Important Bio-Agent (IBA)

8	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2019 - 09/2010
6	Oncogene Proteins (Oncogene Protein)IBA 10/2020 - 03/2011
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 03/2011
5	Phosphotransferases (Kinase)IBA 12/2015 - 04/2009
4	Deubiquitinating EnzymesIBA 01/2019 - 01/2017
3	F-Box ProteinsIBA 01/2012 - 03/2011
2	Caspase 3 (Caspase-3)IBA 01/2023 - 05/2020
2	Sorafenib (BAY 43-9006)FDA Link 01/2023 - 03/2011
2	IntegrinsIBA 10/2022 - 01/2019
2	Mechanistic Target of Rapamycin Complex 2IBA 01/2019 - 11/2013
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2018 - 10/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 02/2015
2	Cyclin EIBA 07/2013 - 03/2011
2	S-Phase Kinase-Associated Proteins (Skp1 Protein)IBA 01/2012 - 01/2012
2	Cullin 1IBA 03/2011 - 09/2010
1	tislelizumabIBA 11/2023
1	B7-H1 AntigenIBA 11/2023
1	CateninsIBA 11/2023
1	Messenger RNA (mRNA)IBA 10/2023
1	Histone DemethylasesIBA 09/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Cytochrome P-450 CYP3AIBA 01/2023
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2023
1	Competitive Endogenous RNAIBA 01/2023
1	lenvatinibIBA 01/2023
1	Cytochrome P-450 CYP2C8IBA 01/2023
1	Cytochrome P-450 CYP2C19IBA 01/2023
1	Cytochrome P-450 CYP2C9IBA 01/2023
1	Monoclonal AntibodiesIBA 11/2022
1	Neutralizing AntibodiesIBA 11/2022
1	AflatoxinsIBA 10/2022
1	AntigensIBA 01/2022
1	Small Cytoplasmic RNAIBA 01/2022
1	Histones (Histone)IBA 11/2021
1	MDL-800IBA 11/2021
1	Lysine (L-Lysine)FDA Link 11/2021
1	Acridine OrangeIBA 05/2020
1	Propidium (Propidium Iodide)IBA 05/2020
1	CaspasesIBA 05/2020
1	Annexin A5IBA 05/2020
1	Antineoplastic Agents (Antineoplastics)IBA 05/2020
1	Ethidium (Ethidium Bromide)IBA 05/2020
1	Sincalide FDA Link 05/2020
1	Rosmarinic AcidIBA 05/2020
1	ProteomeIBA 10/2019
1	Carbon Tetrachloride (Tetrachloromethane)IBA 04/2019
1	NPLC 0393IBA 04/2019
1	Therapeutic UsesIBA 04/2019
1	Methionine AdenosyltransferaseIBA 04/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	CytokinesIBA 01/2019
1	Cullin Proteins (Cullins)IBA 01/2019
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2018
1	GlucocorticoidsIBA 01/2018
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2018
1	VemurafenibIBA 01/2018
1	Sirolimus (Rapamycin)FDA Link 01/2018
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 01/2018
1	MicroRNAs (MicroRNA)IBA 10/2017
1	Cyclin D1IBA 10/2017
1	Carrier Proteins (Binding Protein)IBA 01/2017
1	SirtuinsIBA 01/2017
1	CyclinsIBA 01/2017
1	Ubiquitin-Specific ProteasesIBA 01/2017
1	EnzymesIBA 01/2017
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2017
1	Cyclin-Dependent Kinase Inhibitor p27IBA 01/2017

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 11/2023 - 11/2011
2	Therapeutics 01/2023 - 10/2022
1	Precision Medicine 01/2023